[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360399-105":59,"doc-detail-360399-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-identifies-and-validates-human-circulating-treg-subtypestate-tregfci-in-non-small-cell-lung-cancer","Single-cell identifies and validates human circulating Treg subtype/state Tregfci in non-small cell lung cancer","","Regulatory T cells (Treg) exert immunosuppressive effects in lung cancer and act as key biomarkers in cancer immunology. Using scRNA-seq and stereo-seq, the study aimed to identify a novel circulating Treg subtype/state in non-small cell lung cancer (NSCLC). A regional overlap-expression rate system with cell identity marker gene panels quantified T cell subtype specificity across pre/post-operative blood, multiple diseases, and organs. A FOXP3+CTLA4+IL2RA+ Treg subtype (Tregfci) showed distinct, time- and disease-organ-specific patterns and was enriched pre-operatively and in NSCLC tissue but declined post-operatively. ETS1 upregulation promoted Tregfci migration via cancer cell chemoattraction, modulating metabolism and mitochondrial function. ETS1 regulation was validated in inhibitor-treated human PBMCs and mouse lung tissues, identifying Tregfci/ETS1 as a molecular signature and potential therapeutic target for clinical intervention.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-identifies-and-validates-human-circulating-treg-subtypestate-tregfci-in-non-small-cell-lung-cancer/360399/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-identifies-and-validates-human-circulating-treg-subtypestate-tregfci-in-non-small-cell-lung-cancer/360399.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What Treg subtype/state was identified in this study for NSCLC?","Question",{"text":112,"@type":113},"The study identified Tregfci, defined as FOXP3+CTLA4+IL2RA+, as a distinct circulating Treg subtype/state in non-small cell lung cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did Tregfci change from pre- to post-operative samples?",{"text":117,"@type":113},"Tregfci was prominently enriched in pre-operative blood and NSCLC tissue, but markedly decreased or was absent post-operatively.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does ETS1 play in Tregfci behavior?",{"text":121,"@type":113},"ETS1 was upregulated in Tregfci and promoted its migration from circulation into tumor tissues through cancer cell-derived chemoattraction, while also influencing metabolism and mitochondrial function.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360399,1790210401,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nSingle-cell identiﬁes and validates human circulating Treg subtype/state Tregfci in non-small cell lung cancer  \nXuanqi Liu 1,2, Yifei Liu3, Wanxin Duan2, Jianming Weng4, Hao Dai5, Fangming Liu2, Lingyan Wang2, Mengjia Qian2, Bijun Zhu2, Shuyao Wu6, Youqiong Ye 6, Muhan Yuan2, Shaojun Hong4, Mingjie Wang7, Yunfeng Cheng2 ✉, Tianxiang Chen8,9 ✉, Duojiao Wu2 ✉, Yuanlin Song 1,10 ✉ and Xiangdong Wang1,2 ✉  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Regulatory T cells (Treg) play immunosuppressive roles in lung cancer and are key biomarkers in cancer immunology. Using scRNA-seq and stereo-seq, we aimed to identify a novel circulating Treg subtype in non-small cell lung cancer (NSCLC). We developed a regional overlap-expression rate (rOER) system with cell identity marker gene panels (ciMGPs) to quantify T cell subtype speciﬁcity across pre/ post-operative blood, 31 diseases, and in 17 organs. A Treg subtype (Tregfci, FOXP3+CTLA4+IL2RA+) was identiﬁed and validated for disease-, organ-, and time-speciﬁc characteristics across spatializations, temporalizations, diseases, and prognoses. Tregfci was prominently enriched in pre-operative blood and NSCLC tissue but markedly decreased or was absent post-operatively. Spatial transcriptome and multiplex immunostaining revealed that Tregfci localized primarily to the interface between NSCLC and normal tissues, as well as in speciﬁc micro-niches. ETS Proto-Oncogene 1 (ETS1) was upregulated in Tregfci, conﬁrmed by knockdown and knockout experiments. ETS1 facilitated Tregfci migration from circulation into tumor tissues via cancer cell-derived chemoattraction. Interactions between ETS1 and Tregfci ciMGPs, and between intracellular organelles, were found to modulate metabolism and mitochondrial function. These ﬁndings highlight the importance of Tregfci in understanding the molecular mechanism by which Tregs maintain the balance between systemic and local immune ecosystems. ETS1’s regulation of Tregfci transcriptomic and metabolic proﬁles were conﬁrmed inhuman PBMCs treated with an ETS1 inhibitor and in lung tissues from miceETS1-cKO mice. Furthermore, Tregfci and ETS1 represent a distinct |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | molecular signature of T cells and potential therapeutic targets for clinical intervention in lung cancer. |  |\n|  | Signal Transduction and Targeted Therapy (2026)11:211 ; [https://doi.org/10.1038/s41392-026-02677-6](https://doi.org/10.1038/s41392-026-02677-6) |  |\n|  |  |  |\n\nINTRODUCTION  \nCirculating T cells are critical for maintaining systemic immune homeostasis, orchestrating inter-organ immune coordination, and modulating local microenvironments.1 The discovery of T cell subtypes/states (Ts/s) and identities have expanded rapidly with the advent of single-cell RNA sequencing (scRNA-seq) and the development of cell identity marker gene panels (ciMGPs) . Spatial transcriptomics (Stereo-seq) demonstrates that the distribution and dynamics of Ts/s within tumor microenvironments (TME) are correlated with cancer malignancy, tumor invasion, formation of anti-tumor immune niches, and therapeutic responsiveness.2–5 Circulating T cells play a critical role in stabilizing systemic immune function, mimicking spatialized microenvironmental defense, and reﬂecting inter-organ communication.2,3,6 scRNAseq can reﬁne the abundance, diversity, and characteristics of activated or exacerbated T cells and receptors, as biomarkers for the severity and progression of immune-related adverse events in  \nmelanoma patients treated with immune checkpoint blockade agents.7,8 The delineation of Ts/s deﬁned by scRNA-seq provides novel insights into the T cell atlas, disease-speciﬁc T cell patterns, and interactions between Ts/s","cbCaigb71bTkj2Bc","https://ap.wps.com/l/cbCaigb71bTkj2Bc","pdf",11459783,"English","# Introduction\n## Circulating T cells and T cell subtypes/states\n## Limitations of clinical translation from scRNA-seq\n## Marker selection, plasticity, and metabolic heterogeneity","[{\"question\":\"What Treg subtype/state was identified in this study for NSCLC?\",\"answer\":\"The study identified Tregfci, defined as FOXP3+CTLA4+IL2RA+, as a distinct circulating Treg subtype/state in non-small cell lung cancer.\"},{\"question\":\"How did Tregfci change from pre- to post-operative samples?\",\"answer\":\"Tregfci was prominently enriched in pre-operative blood and NSCLC tissue, but markedly decreased or was absent post-operatively.\"},{\"question\":\"What role does ETS1 play in Tregfci behavior?\",\"answer\":\"ETS1 was upregulated in Tregfci and promoted its migration from circulation into tumor tissues through cancer cell-derived chemoattraction, while also influencing metabolism and mitochondrial function.\"}]","Single-cell identifies and validates human circulating Treg subtype/state Tregfci in non-small cell lung cancer | PDF",1790139943,76,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/378a25a9e00577abf1add55e6c3d2834.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2841cb1dd05a18d7a842ef5e1ba0f8c9.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c406ce7b3bcd9d5187e98048ff7be93.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e324e433ea8beceac61fd03b92bdf45.webp",980,1301]